Loading…
IceCure Medical Ltd is projected to rise to $4.88 by 2027, a +34% move from its current price of $3.65. ICCM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $3.32 | $3.65 | $4.02 | +0.01% |
| Jul 14 | $3.19 | $3.65 | $4.18 | +0.02% |
| Jul 15 | $3.09 | $3.65 | $4.31 | +0.04% |
| Jul 16 | $3.01 | $3.65 | $4.43 | +0.05% |
| Jul 17 | $2.95 | $3.65 | $4.53 | +0.06% |
| Jul 18 | $2.89 | $3.65 | $4.62 | +0.07% |
| Jul 19 | $2.83 | $3.65 | $4.71 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.83 | $3.65 | $4.71 | +0.09% |
| Week 2 | $2.55 | $3.66 | $5.24 | +0.17% |
| Week 3 | $2.36 | $3.66 | $5.69 | +0.26% |
| Week 4 | $2.20 | $3.66 | $6.09 | +0.34% |
| Week 5 | $2.08 | $3.67 | $6.47 | +0.43% |
| Week 6 | $1.97 | $3.67 | $6.84 | +0.52% |
| Week 7 | $1.87 | $3.67 | $7.20 | +0.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IceCure Medical Ltd is a commercial-stage medical device company focused on cryoablation technologies for tumor treatment. It operates across the United States, Japan, India, China, Israel, and internationally.
Its product portfolio includes the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its disposables, including CryoProbes needles and guiding needles/introducers. It also develops and markets the IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology, and it is advancing XSense and MSense for single-probe and multi-probe applications.
IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd trades under the ICCM symbol. The current price is $3.65, and the company has a market capitalization of $12.51M.
The stock is ranked 5030 in market cap size, reflecting its relatively small position in the market.
Forecasts provide a year-by-year view of the price trajectory, with 2026 showing min $2.13, avg $3.65, max $5.46 and sentiment Neutral. The outlook improves in subsequent years, with rising averages and positive ROI in 2027–2029 and meaningful upside in the longer term (2030, 2040, 2050), including a 2050 average of $11.28 and a max of $25.94.
A major floor 96.3% below — a decisive break under it would weaken the trend.
The nearest floor, 41.6% below — buyers have tended to step in here.
The nearest ceiling, 154.8% above — a clean break opens room to run.
A major ceiling 270.6% above — clearing it would confirm fresh momentum.
Key ICCM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICCM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.08 | Sell | $4.13 | Sell |
| MA 10 | $4.71 | Sell | $4.51 | Sell |
| MA 20 | $4.83 | Sell | $4.36 | Sell |
| MA 50 | $2.42 | Buy | $3.09 | Buy |
| MA 100 | $1.46 | Buy | $2.09 | Buy |
| MA 200 | $1.09 | Buy | $1.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.74 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -57.60 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.40 | Sell |
| ROC (12) | -40.36 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 4.44 | Buy |
| Awesome (5,34) | 0.64 | Buy |
| Ultimate (7,14,28) | 32.99 | Neutral |
| Momentum (10) | -3.37 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 3.58 | Buy |
| ADX (14) | 22.18 | Sell |
| ATR (14) | 0.65 | Info |
The current price is below both the 50-day and 200-day moving averages, indicating a bearish near-term tone (SMA50 is $5.86 and SMA200 is $16.08).
The 30-day trading range runs from $1.94 to $6.88, with a support level at $2.13 and a resistance at $9.30. The stock’s price action remains pressured, consistent with the bearish sentiment noted in the indicators.
Annualized volatility runs high at 200%, underscoring the heightened risk and rapid potential for price swings in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.13 | $3.65 | $5.46 | 0% | Neutral | |
| $3.54 | $4.88 | $7.27 | +34% | Bullish | |
| $4.03 | $5.90 | $9.37 | +62% | Bullish | |
| $3.19 | $4.92 | $8.20 | +35% | Bullish | |
| $2.58 | $4.18 | $7.25 | +14% | Neutral | |
| $2.83 | $4.78 | $8.58 | +31% | Bullish | |
| $2.42 | $4.26 | $7.90 | +17% | Neutral | |
| $3.03 | $5.56 | $10.58 | +52% | Bullish | |
| $3.64 | $6.96 | $13.58 | +91% | Bullish | |
| $3.15 | $6.26 | $12.51 | +72% | Bullish | |
| $3.94 | $8.77 | $19.24 | +140% | Bullish | |
| $5.08 | $11.28 | $25.94 | +209% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.13 | $3.65 | $4.77 | +0.00% |
| August 2026 | $3.18 | $3.85 | $4.86 | +5.42% |
| September 2026 | $3.00 | $3.69 | $4.76 | -4.07% |
| October 2026 | $3.17 | $3.95 | $5.18 | +6.97% |
| November 2026 | $3.32 | $4.17 | $5.54 | +5.54% |
| December 2026 | $3.19 | $4.05 | $5.46 | -2.82% |
Click any year to see its month-by-month ICCM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ICCM price prediction for 2026 points to an average of $3.65 (low $2.13, high $5.46) — a potential gain of 0% on today's $3.65. A consolidation phase looks the most probable path here.
In 2027, ICCM is projected to trade between $3.54 and $7.27, averaging $4.88 — a potential gain of +34% from today's $3.65. That is up +34% on the projected 2026 average. Momentum favours further upside here.
IceCure Medical Ltd's 2028 outlook centres on $5.90, within a $4.03 to $9.37 range. That is up +21% on the projected 2027 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ICCM could reach as high as $8.20, with a base case around $4.92 and support toward $3.19 — roughly +35% from $3.65. Momentum favours further upside here.
Expect ICCM to range from $2.58 to $7.25 through 2030. The $4.18 average target implies a +14% move from current prices. That is -15% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The ICCM price prediction for 2031 points to an average of $4.78 (low $2.83, high $8.58) — a potential gain of +31% on today's $3.65. Momentum favours further upside here.
In 2032, ICCM is projected to trade between $2.42 and $7.90, averaging $4.26 — a potential gain of +17% from today's $3.65. That is -11% versus the projected 2031 average. A consolidation phase looks the most probable path here.
IceCure Medical Ltd's 2033 outlook centres on $5.56, within a $3.03 to $10.58 range. That is up +30% on the projected 2032 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2034, ICCM could reach as high as $13.58, with a base case around $6.96 and support toward $3.64 — roughly +91% from $3.65. Buyers look set to stay in control over this stretch.
Expect ICCM to range from $3.15 to $12.51 through 2035. The $6.26 average target implies a +72% move from current prices. That is -10% versus the projected 2034 average. Momentum favours further upside here.
The ICCM price prediction for 2040 points to an average of $8.77 (low $3.94, high $19.24) — a potential gain of +140% on today's $3.65. Buyers look set to stay in control over this stretch.
In 2050, ICCM is projected to trade between $5.08 and $25.94, averaging $11.28 — a potential gain of +209% from today's $3.65. That is up +29% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ICCM today (≈ 273.972603 ICCM) could be worth
$3,090.23
+$2,090.23 (+209%) by 2050 · US Dollar
Based on the average projected ICCM price of $11.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICCMwould be worth at today's price.
$1,000 invested in ICCM on Jul 10, 2025 (≈ 990.099019 ICCM) would be worth
$3,613.86
+$2,613.86 (+261.4%) today · 3.61× · US Dollar
Based on a ICCM entry price of $1.01 vs. today's $3.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.36 | $680.97 | -31.9% |
| 1 month ago | $2.54 | $1,437.01 | +43.7% |
| 3 months ago | $0.323 | $11,300.31 | +1030.0% |
| 6 months ago | $0.672 | $5,431.55 | +443.2% |
| 1 year ago | $1.01 | $3,613.86 | +261.4% |
| All time (5.0y) ago | $9.81 | $371.99 | -62.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICCM forecast.
Our base-case forecast reaches $7.30 around 2040.
Implied market cap at $7.30: $25.01M
The multi-year forecast shows a gradual path upward after the near-term neutral stance. For 2027 the avg is $4.88 with ROI 33.6 and a bullish sentiment, followed by 2028 at avg $5.90 with ROI 61.7 and bullish sentiment, and 2029 at avg $4.92 with ROI 34.7. The trajectory remains mixed through 2030 (avg $4.18, ROI 14.5, neutral) before accelerating in the longer horizon.
In the longer horizon, 2033–2035 show notable upside with 2033 avg $5.56 and ROI 52.2, 2034 avg $6.96 and ROI 90.6, and 2035 avg $6.26 and ROI 71.6, all bullish. The forecast extends to 2040 with avg $8.77 and ROI 140.2, and to 2050 with avg $11.28 and ROI 209, both bullish. These figures illustrate meaningful upside potential but remain estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows min $2.58, avg $4.18, max $7.25 with ROI 14.5 and sentiment NEUTRAL.
Forecasts indicate bullish sentiment in multiple years (e.g., 2027, 2028, 2029, 2031, 2033–2035, 2040, 2050) with rising averages and ROI up to 209. However, near term shows neutral sentiment (2026) and results are estimates, not guarantees.
Yes. The forecast shows a 2050 average of $11.28 (max $25.94) and a 2034 max of $13.58, implying levels above $10 in the longer term.
For 2026, the min is $2.13, avg is $3.65, max is $5.46, with sentiment NEUTRAL.
2040 is forecast at avg $8.77 with ROI 140.2 and bullish sentiment; 2050 is forecast at avg $11.28 with ROI 209 and bullish sentiment.
IceCure Medical Ltd Community Discussion
0Share your IceCure Medical Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.